An exploratory analysis of the cost‐effectiveness of insulin glargine 300 units/mL versus insulin glargine 100 units/mL over a lifetime horizon using the BRAVO diabetes model
Article in Diabetic Medicine (March 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Diabetic Medicine (March 2024)
Article in Advanced Drug Delivery Reviews (October 2023)
Article in Diabetes Metabolic Syndrome and Obesity (January 2021)